Up next

Autoplay

BeiGene’s Brukinsa (zanubrutinib): a newly approved treatment medicine for mantle cell lymphoma (MCL

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

What is mantle cell lymphoma? What is Brukinsa? What is Brukinsa zanubrutinib? What is mechanism of action of zanubrutinib? What are the side effects of Brukinsa? What is a indication of zanubrutinib? What is use of Brukinsa? What are BTK inhibitors?

This vedio contains information on a newly approved drug zanubrutinib which is recently approved for treatment of mantle cell lymphoma, which may be helpful to medical, pharmacy, nursing, dental students and professionals.


Thank you for watching this Video. Please subscribe, share and hit the bell icon for more such videos. Please visit my blog: https://www.medicalinfo4u.com/

Please check out my other videos below:

Carcinoma of Pancreas or Pancreatic Cancer: Risk factors, Symptoms, Diagnosis and treatment: https://youtu.be/lLoYQcXZvYE


Squamous cell carcinoma of skin https://youtu.be/T91mQPiDp8M


Basal cell carcinoma of skin (Rodent ulcer/ Tear cancer) https://youtu.be/XSTQ0kA-7kw


Prostate cancer https://youtu.be/Arun9pe4ZJM


Malignant melanoma of skin: https://youtu.be/1_Qn9lzSluc


FDA found low levels of cancer causing substances in Ranitidine medicine (Zantac): https://youtu.be/ImR5TVnV5Wk


Medical disclaimer: This video is just for education purpose and does not provide any medical advice, a diagnosis or other recommendation for treatment. An advice of a physician or other qualified healthcare should always be taken in diagnosis and treatment of any condition.

#MedicalInfo4U
#Mantlecelllymphoma
#lymphoma
#Brukinsa
#zanubrutinib
#refractorylymphoma
#relapsedlymphoma
#Bruton'styrosinekinase
#BTK
#Ibrutinib
#Imbruvica
#Acalabrutinib
#Calquence

Show more
0 Comments sort Sort By

Up next

Autoplay